Chemoinformaics analysis of E-Isoeugenyl benzyl ether
| Molecular Weight | 254.329 | nRot | 5 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 13 |
| Exact Molecular Weight | 254.131 | nRing | 2 |
| Solubility: LogS | -5.026 | nHRing | 0 |
| Solubility: LogP | 4.23 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 41.9963 |
| nHD | 0 | BPOL | 21.5297 |
| QED | 0.791 |
| Synth | 1.696 |
| Natural Product Likeliness | 0.006 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.954 |
| Pgp-sub | 0.007 |
| HIA | 0.003 |
| CACO-2 | -4.785 |
| MDCK | 0.000021 |
| BBB | 0.221 |
| PPB | 0.982451 |
| VDSS | 1.04 |
| FU | 0.0208687 |
| CYP1A2-inh | 0.973 |
| CYP1A2-sub | 0.953 |
| CYP2c19-inh | 0.95 |
| CYP2c19-sub | 0.595 |
| CYP2c9-inh | 0.762 |
| CYP2c9-sub | 0.89 |
| CYP2d6-inh | 0.116 |
| CYP2d6-sub | 0.915 |
| CYP3a4-inh | 0.2 |
| CYP3a4-sub | 0.755 |
| CL | 11.953 |
| T12 | 0.612 |
| hERG | 0.48 |
| Ames | 0.292 |
| ROA | 0.015 |
| SkinSen | 0.941 |
| Carcinogencity | 0.311 |
| EI | 0.688 |
| Respiratory | 0.109 |
| NR-Aromatase | 0.118 |
| Antiviral | No |
| Prediction | 0.692784 |